Cowen and Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$72.6M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$33.7M |
| 3 |
CUTR
Cutera, Inc.
CUTR
|
+$31.5M |
| 4 |
Adicet Bio
ACET
|
+$13M |
| 5 |
RBAC
RedBall Acquisition Corp.
RBAC
|
+$12.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$26.8M |
| 2 |
PMV Pharmaceuticals
PMVP
|
+$26.3M |
| 3 |
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
|
+$16.9M |
| 4 |
Fulcrum Therapeutics
FULC
|
+$10.4M |
| 5 |
American Express Global Business Travel
GBTG
|
+$7.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.69% |
| 2 | Financials | 13.57% |
| 3 | Materials | 7.25% |
| 4 | Technology | 4.61% |
| 5 | Industrials | 3.75% |
Similar funds
Cowen and Company's Q2 2022 Portfolio in Review
As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.
- Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
- Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
- Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
- Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
- Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
- Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
- Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.
Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.